Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q2 2017)

As of Jun 30, 2017, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 14, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2017, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q2 2017
39115V101
Great Panther
Sell
-51,500
Q2 2017
A
Agilent Technologies, Inc.
Sell - Position Exit
-559,100
Q2 2017
AA
Alcoa Corporation
Sell
-784,500
Q2 2017
AAME
Atlantic American Corporation
Buy
+400
Q2 2017
AAOI
Applied Optoelectronics, Inc.
Sell - Position Exit
-514,000
Q2 2017
AAON
AAON, Inc.
Sell
-61,300
Q2 2017
AAP
Advance Auto Parts Inc.
Sell - Position Exit
-198,550
Q2 2017
AAPL
Apple Inc.
Buy - Position Entry
+584,433
Q2 2017
AB
AllianceBernstein Holding L.P.
Sell
-88,625
Q2 2017
ABBNY
ABB Ltd.
Buy
+108,763
Q2 2017
ABBV
AbbVie Inc.
Buy
+1,132,400
Q2 2017
ABCB
Ameris Bancorp
Sell
-32,500
Q2 2017
ABEV
Ambev S.A.
Buy
+4,423,500
Q2 2017
ABG
Asbury Automotive Group Inc
Buy - Position Entry
+15,100
Q2 2017
ABR
Arbor Realty Trust
Sell
-16,037
Q2 2017
ABT
Abbott Laboratories
Sell
-2,058,700
Q2 2017
ABUS
Arbutus Biopharma Corporation
Buy
+85,666
Q2 2017
AC
Associated Capital Group, Inc.
Buy
+34,800
Q2 2017
ACCO
Acco Brands Corporation
Sell
-186,400
Q2 2017
ACHC
Acadia Healthcare Company, Inc.
Sell - Position Exit
-275,200
Q2 2017
ACIW
ACI Worldwide, Inc.
Buy - Position Entry
+366,633
Q2 2017
ACLS
Axcelis Technologies, Inc.
Buy - Position Entry
+63,099
Q2 2017
ACM
AECOM
Sell
-332,933
Q2 2017
ACNB
ACNB Corporation
Buy
+7,056
Q2 2017
ACNT
Ascent Industries Co.
Sell
-8,481
Q2 2017
ACRE
Ares Commercial Real Estate Cor
Sell - Position Exit
-68,300
Q2 2017
ACRS
Aclaris Therapeutics, Inc.
Sell
-59,179
Q2 2017
ACTG
Acacia Research Corporation
Buy
+68,200
Q2 2017
ACU
Acme
Buy
+17,700
Q2 2017
ADAP
Adaptimmune Therapeutics plc
Buy
+288,500
Page 1 of 64